Dose-ranging and safety with intravenous levosimendan in low-output heart failure: experience in three pilot studies and outline of the levosimendan infusion versus dobutamine (LIDO) trial

Dose-ranging and safety with intravenous levosimendan in low-output heart failure: experience in three pilot studies and outline of the levosimendan infusion versus dobutamine (LIDO) trial

A series of dose-ranging and tolerability studies of intravenous levosimendan (bolus then infusion) were conducted in 40 patients with low-output heart failure (cardiac index

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of cardiology 1999-06, Vol.83 (12), p.21-25
Hauptverfasser: Folláth, Ferenc, Hinkka, Susanna, Jäger, Detlef, Just, Hanjörg, Mitrovic, Veselin, Papp, Julius Gy, Peuhkurinen, Keijo, Sandell, Esa-Pekka, Takkunen, Olli, Lehtonen, Lasse
Format: Artikel
Sprache:eng
Schlagworte:
Cardiology
Clinical trials
Drug therapy
Heart failure
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A series of dose-ranging and tolerability studies of intravenous levosimendan (bolus then infusion) were conducted in 40 patients with low-output heart failure (cardiac index
ISSN:0002-9149
1879-1913
DOI:10.1016/S0002-9149(99)00314-8